Skip to content

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated November 15, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish